Emergent Biosolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 20.73
    Last
  • 0.58  -2.72%
    Today's Change
  • 21.31
    Previous Close
  • Today
     
    17.31
    28.48
    52 Week Low - High
4:15 pm ET 10/1/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding37 million
Market Cap$777 million
Return on Equity ttm2.88%
Last DividendEBS:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.562
EPS: Year Est. 12/14 ttm0.997
 
EPS: Quarterly Actual 6/14 0.13
EPS: Quarterly Est. 9/14 0.47
 
Price/Earnings ttm36.87
Relative Price/Earnings2.060
Earnings Growth Rate32.31
Company Description
Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$313 million
Net Income$31 million
Total Assets$627 million
Employees1,353
Web Sitewww.emergentbiosolutions.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!